Welcome to the most comprehensive peptide guide available for researchers, biohackers, and health optimizers entering the world of research peptides in 2026. Whether you have been reading about BPC-157 for tissue repair, exploring growth hormone secretagogues like CJC-1295 and Ipamorelin, or simply trying to understand what separates a peptide from a protein or a steroid, this guide covers every foundational concept you need before you begin. We have written this resource to be scientifically grounded, practically useful, and honest about what the current research does and does not support.
What Are Peptides and How Do They Work
A peptide is a short chain of amino acids linked together through peptide bond formation. Understanding amino acid sequence and peptide bond formation is the first step in any serious peptide guide, because these two concepts define everything that follows. When two amino acids join, the carboxyl group of one reacts with the amino group of another, releasing water and creating a covalent peptide bond. Chain those bonds together and you get a peptide. Add more amino acids and increase molecular weight significantly, and eventually you have a protein. The distinction is largely one of size: peptides typically contain fewer than 50 amino acids, while proteins are longer, more structurally complex molecules that fold into three-dimensional shapes to carry out enzymatic, structural, or carrier functions.
This size difference matters enormously in research contexts. Because peptides are smaller, many of them can interact with specific cell surface receptors in highly targeted ways. Receptor binding and signal transduction are the mechanisms through which peptides produce their observed effects. A peptide molecule docks with a receptor protein on a cell membrane, triggering a conformational change that initiates an intracellular signaling cascade. That cascade might stimulate the release of growth hormone, accelerate tissue repair, modulate inflammation, or influence gene expression, depending on which receptor is activated and in which tissue.
So how is a peptide different from a steroid? The answer is fundamental. Steroids are lipid-derived molecules built from a cholesterol backbone. They pass directly through cell membranes and bind to intracellular receptors, eventually influencing nuclear transcription. Peptides, being water-soluble chains of amino acids, cannot cross the lipid bilayer of a cell membrane the same way. They work from the outside in, through receptor binding on the cell surface. This distinction also explains why most research peptides must be administered by injection rather than swallowed as oral tablets. Digestive enzymes would simply break down the amino acid chain before it could reach the bloodstream intact, dramatically reducing bioavailability.
There is also an important conceptual line between endogenous and synthetic peptides. Endogenous peptides are those naturally produced within the body. Insulin is a peptide. Oxytocin is a peptide. Growth hormone releasing hormone (GHRH) is a peptide produced by the hypothalamus. Synthetic peptides are laboratory-synthesized compounds designed to mimic, amplify, or modulate the activity of these naturally occurring signaling molecules. Many research peptides are analogues of endogenous compounds, meaning they share a similar amino acid sequence but include structural modifications that extend half-life, improve receptor affinity, or resist enzymatic degradation. For a broader scientific overview of peptide biochemistry, the National Library of Medicine PubMed database is the most authoritative public repository of peer-reviewed peptide research available.
Types of Peptides and Their Research Applications: A Peptide Guide by Category
Research peptides are generally categorized by their primary mechanism of action and the physiological systems they target. Understanding these categories is central to any functional peptide guide because it allows researchers to match a compound class to a specific research objective before drilling down into individual compounds.
Growth Hormone Secretagogues
Growth hormone secretagogues are peptides that stimulate the release of growth hormone (GH) from the anterior pituitary gland. They do this by interacting with the hypothalamic-pituitary axis, either by mimicking GHRH (growth hormone releasing hormone) or by acting on ghrelin receptors. CJC-1295 is a GHRH analogue that amplifies the natural pulsatile release of GH. Ipamorelin is a selective GHRP, or growth hormone releasing peptide, that acts as a ghrelin mimetic. Sermorelin is another endogenous GHRH analogue with a shorter half-life than CJC-1295, making it a common starting point for researchers interested in GH axis modulation with a more conservative pharmacokinetic profile.
Because growth hormone secretagogues work upstream of the pituitary, they preserve the natural feedback mechanisms of the hypothalamic-pituitary axis rather than introducing exogenous GH directly. This is considered an important distinction from a safety and hormonal axis interaction standpoint.
Tissue Repair and Regenerative Peptides
BPC-157, formally known as Body Protection Compound and classified as a pentadecapeptide, is one of the most extensively researched peptides in this category. BPC-157 and tissue repair and gut healing are closely linked in the literature, with preclinical studies examining its role in tendon regeneration, gastrointestinal mucosal healing, and angiogenesis. It is a partial sequence derived from a protein found in human gastric juice. TB-500, which is a synthetic fragment of Thymosin Beta-4, is an actin-binding peptide that has shown relevance in wound healing, muscle repair, and reducing inflammation in preclinical models.
Longevity and Anti-Aging Peptides
Epithalon, also written as Epitalon, is a telomere-related tetrapeptide derived from the pineal gland. It was originally developed by Russian researcher Vladimir Khavinson and has been studied in the context of telomerase activation, circadian rhythm regulation, and age-related hormonal decline. While the human data remains limited, Epithalon represents an interesting category for researchers exploring longevity-focused peptide applications.
How to Choose the Right Peptide for Your Research Goals
One of the most practical questions in any peptide guide is how to match a compound to a specific research objective. The answer starts with being honest about what the existing evidence supports and what it does not.
For researchers focused on tissue repair and recovery, BPC-157 and TB-500 are the most commonly explored starting points, supported by a growing volume of preclinical data. For those interested in GH axis research, the CJC-1295 and Ipamorelin combination is frequently discussed in the research community because the two compounds target complementary mechanisms: CJC-1295 amplifies the GHRH signal while Ipamorelin triggers the ghrelin receptor pathway. Using them together can produce a more pronounced and cleaner GH pulse compared to either compound alone.
The question of what the difference is between CJC-1295 with DAC and CJC-1295 without DAC comes up frequently in beginner discussions. DAC stands for Drug Affinity Complex, a modification that binds the peptide to albumin in the bloodstream, dramatically extending its half-life from minutes to approximately 8 days. CJC-1295 without DAC (also sold as Modified GRF 1-29) has a half-life of roughly 30 minutes and is dosed immediately before sleep to coincide with the natural GH pulse. CJC-1295 with DAC is dosed once or twice weekly. Most beginner-oriented researchers prefer the without-DAC version because it allows for more granular control over timing and pulse mimicry.
For a complete first cycle, most experienced researchers recommend starting with a single compound rather than a stack. This allows you to observe how a given peptide affects your research subject without confounding variables. Once baseline responses are established, peptide stacking principles can be applied to combine compounds for synergistic research outcomes.
Peptide Dosing Guide: Reconstitution, Unit Conversion, and Administration
Proper dosing is arguably the section of this peptide guide that will have the most direct impact on your research outcomes. Errors in reconstitution or dose calculation are among the most common mistakes beginners make, and some of those errors can compromise both the integrity of the compound and the safety of the research protocol.
Reconstituting Lyophilized Peptides
Research peptides are sold in lyophilized powder form, meaning they have been freeze-dried to remove moisture and extend shelf stability. To use them, you must reconstitute the lyophilized peptide using bacteriostatic water. The bacteriostatic water reconstitution protocol matters because using plain sterile water instead of bacteriostatic water (which contains 0.9% benzyl alcohol as a preservative) will allow bacterial growth in the vial after the first use, degrading the compound and creating a contamination risk.
To reconstitute correctly, draw the desired volume of bacteriostatic water into a U-100 insulin syringe and inject it slowly down the inside wall of the peptide vial. Do not inject directly onto the lyophilized powder with force. Do not shake the vial. Gently swirl it until the powder is fully dissolved. The resulting solution should be clear and colorless. If it appears cloudy, particulate, or discolored, do not use it.
The amount of bacteriostatic water you add determines the concentration of your solution, which then determines the volume you draw for each dose. A common example: if you have a 5 mg vial of BPC-157 and you add 2 mL (2,000 mcL) of bacteriostatic water, your concentration is 2.5 mg per mL, or 2,500 mcg per mL. A 250 mcg dose from that solution requires 0.1 mL, which equals 10 units on a U-100 insulin syringe.
Microgram to Insulin Syringe Unit Conversion
Understanding the relationship between the insulin syringe and microgram to unit conversion is essential. A U-100 insulin syringe holds 1 mL of liquid and is marked in 100 units, meaning each unit equals 0.01 mL. To calculate the number of units for a given dose, divide the desired dose in mcg by the concentration in mcg per mL, then multiply by 100.
For example, using the same 2,500 mcg per mL BPC-157 solution: a 500 mcg dose requires (500 divided by 2,500) multiplied by 100, which equals 20 units on the syringe. Writing out this calculation before every administration session eliminates the most common source of dosing errors in beginner research protocols. Many researchers keep a laminated reference card with their current vial concentration and corresponding unit values for common doses.
Injection Routes and Technique
Most research peptides are administered subcutaneously, meaning the injection is delivered into the fatty tissue layer just below the skin. Common subcutaneous injection sites include the abdomen, outer thigh, and lower back. The needle is inserted at roughly a 45-degree angle using a short, fine-gauge needle. A 29- or 31-gauge needle on a U-100 insulin syringe is standard. Intramuscular administration is used less frequently in peptide research but may be relevant for certain compounds where slightly faster absorption is desired.
Injection site rotation is important in extended research protocols. Repeating injections at the same location can cause localized lipodystrophy over time. Rotating systematically across several sites reduces this risk and maintains consistent absorption characteristics.
Peptide Storage: How to Preserve Compound Integrity
Correct storage is a non-negotiable element of any reliable peptide guide. Peptides are sensitive molecules. Exposure to heat, light, repeated freeze-thaw cycles, and contamination can degrade the amino acid chain and reduce or eliminate biological activity. Understanding the difference between pre- and post-reconstitution storage conditions is critical.
Lyophilized peptide vials that have not yet been reconstituted should be stored in a cool, dark environment. Refrigeration at 2 to 8 degrees Celsius is appropriate for short-term storage spanning several months. For longer-term storage, many researchers keep lyophilized vials at minus 20 degrees Celsius in a freezer. Under these conditions, most research peptides remain stable for 12 to 24 months, though this varies by compound and manufacturer. Always keep vials away from direct light, as ultraviolet exposure can break peptide bonds.
Once reconstituted with bacteriostatic water, the peptide solution should be stored at 2 to 8 degrees Celsius and used within 28 to 30 days. The benzyl alcohol preservative in bacteriostatic water suppresses bacterial growth during this window, but it does not indefinitely preserve biological activity. Do not freeze a reconstituted solution. Freezing can cause protein aggregation and degrade the peptide. If you will not use a reconstituted vial within 30 days, it is better to prepare smaller volumes more frequently rather than reconstituting large batches.
Every time you draw from a vial, use a fresh, sterile needle. Introducing a previously used needle into a vial risks contaminating the entire solution. Inspect every vial before each use. Cloudiness, floating particles, or color change are all signs that a solution has degraded or been contaminated and should be discarded.
Peptide Safety, Side Effects, and Research Considerations
No honest peptide guide would be complete without a thorough discussion of safety. Research peptides operate in a regulatory space that requires careful understanding, and many compounds covered in this guide have not been approved by the FDA for human therapeutic use. They are sold legally for research purposes only, which places significant responsibility on the researcher to understand both the science and the limitations of the available data.
Common Side Effects by Compound Class
Growth hormone secretagogues are generally considered well-tolerated in research contexts, but several side effects are worth noting. Water retention is one of the most commonly reported effects, resulting from GH-stimulated sodium retention in the kidneys. Increased hunger is another frequently observed effect, particularly with GHRP-class compounds like Ipamorelin and GHRP-2, which interact with ghrelin pathways that regulate appetite. Mild tingling or numbness in the extremities can occur if GH levels rise substantially. Cortisol and prolactin elevations are less common with selective compounds like Ipamorelin but more likely with less selective GHRPs such as GHRP-6.
BPC-157 has a notably favorable safety profile in preclinical literature, with few adverse effects reported across a wide range of animal studies. However, because large-scale human clinical trial data is not yet available, extrapolation of preclinical findings to human applications requires caution. Nausea and dizziness have been occasionally reported anecdotally, particularly at higher doses or when administration is not subcutaneous.
Contraindications and Research Red Lines
Researchers should be aware that several compound categories carry specific contraindication signals. Growth hormone secretagogues are contraindicated in any context involving active malignancy, as GH and IGF-1 can promote cellular proliferation. Diabetic or pre-diabetic research contexts require careful consideration because GH elevation can impair insulin sensitivity. Any research protocol involving hormonal axis modulation warrants baseline bloodwork to establish reference ranges before and after a research cycle.
Injection hygiene is a safety concern that transcends any specific compound. Sterile technique, appropriate disposal of sharps, and vigilance for signs of injection site infection are baseline requirements for any research protocol involving subcutaneous or intramuscular administration. Redness, swelling, warmth, or discharge at an injection site that does not resolve within 24 to 48 hours should prompt immediate medical evaluation.
Sourcing and Legal Status: What Every Peptide Guide Must Address
The sourcing landscape for research peptides is one of the most important and least discussed topics in this space. The quality of a peptide compound is only as reliable as the supplier producing and testing it. Because research peptides are not regulated as pharmaceutical products in most jurisdictions, quality control varies dramatically between vendors.
When evaluating a research peptide supplier, the most important indicator of quality is independent third-party testing. Reputable suppliers provide Certificates of Analysis (COAs) from accredited independent laboratories confirming peptide purity (typically expressed as a percentage, with 98% or higher being a common threshold for quality research-grade material), identity verification via mass spectrometry or HPLC, and absence of harmful contaminants including heavy metals, bacterial endotoxins, and residual solvents.
From a legal standpoint, research peptides occupy a nuanced position. In the United States, compounds that are not approved drugs and are not sold for human consumption may be sold legally for in vitro research purposes. However, the regulatory landscape is evolving, and certain compounds have been placed under increased scrutiny by the FDA. Researchers should stay informed about current regulatory status for any compound they plan to work with. This peptide guide does not constitute legal advice, and researchers are encouraged to consult applicable regulations in their jurisdiction before procuring research compounds.